Press release
Autoimmune Disease Diagnostics Market projected to expand at a CAGR of 3.8% from 2019 to 2027
Transparency Market Research (TMR) has published a new report titled, ‘Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in 2018 and is projected to expand at a CAGR of 3.8% from 2019 to 2027.Overview
In autoimmune disease body's immune system attacks its own healthy cells. There are at least 80 types of autoimmune diseases. Autoimmune disease diagnostics include various tests such as antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, and urinalysis that aid in the diagnosis of autoimmune diseases
North America was the largest market for autoimmune disease diagnostics in 2018 due to increased awareness about advanced diagnostic techniques and increasing government initiatives. For instance, the American Autoimmune Related Diseases Association, Inc. (AARDA) and the National Institutes of Health (NIH) initiated different programs for the development and advancement of autoimmune disease treatment and diagnosis in the U.S.
Asia Pacific is likely to be a highly lucrative market for autoimmune disease diagnostics and it is expected to expand at a high CAGR during the forecast period. Adoption of new and sophisticated technologies, advances in diagnostic technologies, and increasing partnership of governments with private players and clinical laboratories are likely to propel the growth of market during the forecast period. For instance, India-based SRL Diagnostics partnered with state governments to set up and operate 24 labs in large state-run hospitals in various districts.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351
Growing Awareness among People about Autoimmune Diseases and High Prevalence of Autoimmune Diseases across the World to Drive Market
Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market. Furthermore, governments across countries are taking various initiatives and organizing programs in order to create awareness among the people about autoimmune diseases. For instance, the American Autoimmune Related Diseases Association, Inc. (AARDA) and the National Institutes of Health (NIH) initiated various programs for the development and advancement of autoimmune disease treatment and diagnosis in the U.S.
Rising prevalence of autoimmune diseases is likely to fuel the growth of the autoimmune disease diagnostics market. Therefore, consistent increase in the autoimmune patient population across the world has been identified as one of the major factors driving the autoimmune disease diagnostics market.
Request for Analysis of COVID19 Impact on Autoimmune Disease Diagnostics Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=5351
Autoantibody Test Segment to Dominate Market
Based on test type, the global autoimmune disease diagnostics market has been divided into antinuclear antibody test, autoantibody test, complete blood count (CBC), comprehensive metabolic panel, c-reactive protein (CRP) test, erythrocyte sedimentation rate (ESR), urinalysis and others.
Autoantibody test segment dominated the global autoimmune disease diagnostics market in 2018 and the trend is projected to continue during the forecast period. Autoantibody tests are performed when a patient is suffering from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. Initially, antinuclear antibody (ANA) test is performed (a primary test to evaluate a person for autoimmune disorders) and is frequently followed up with other specific autoantibody tests such as anti-Sjögren’s syndrome A (anti-SSA/Ro), anti-double strand DNA (anti-dsDNA), anti-Sjögren’s syndrome B (anti-SSB/La), and anti-ribonucleic protein (anti-RNP), etc.
An article published by the American Association for Clinical Chemistry, stated that over 32 million people in the U.S. have autoantibodies, with antinuclear antibody the most prevalent and common type of antibodies present among women, older individuals, and African-Americans
Buy Autoimmune Disease Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=5351<ype=S
Competitive Landscape
The global autoimmune disease diagnostics market is fragmented in terms of number of players. Key players in the global market include Abbott Laboratories, Inc., Beckman Coulter, Inc. , bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics, Inc., Quest Diagnostics, SQI Diagnostics, Inc., Siemens Healthcare among others
Browse More Trending Reports by Transparency Market Research:
Hemophilia Treatment Drugs Market :
https://www.prnewswire.com/news-releases/increased-research-and-development-activities-driving-expansion-of-global-hemophilia-treatment-drugs-market-tmr-301175895.html
Motion Preservation Devices Market:
https://www.prnewswire.com/news-releases/increased-cases-of-spinal-disorders-generate-prominent-demand-opportunities-for-motion-preservation-devices-market-tmr-301181550.html
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Disease Diagnostics Market projected to expand at a CAGR of 3.8% from 2019 to 2027 here
News-ID: 2296132 • Views: …
More Releases from Transparancy Market Research

Quantum Dot Sensor Market is expected to Progress at a CAGR of 20.9% to reach US …
The Quantum Dot Sensor Market is experiencing significant growth due to the increasing demand for advanced imaging and sensing technologies across various industries. Quantum dot sensors utilize quantum dots as photoactive materials, enabling enhanced sensitivity and accuracy in detecting light, colors, and other signals. These sensors are finding applications in sectors such as healthcare, consumer electronics, automotive, and defense.
The global quantum dot sensor market is projected to grow at a…

Medium-voltage Switchgear Market Value to Reach USD 44 Billion by 2031,TMR Study
Medium-voltage switchgear market serves as an essential component in power distribution networks, enabling the safe and efficient control of electrical power between medium-voltage sources and consumers. It finds applications across industries such as utilities, industrial, commercial, and residential sectors.
Medium-voltage Switchgear market will likely reach a valuation of US $44 billion by the conclusion of 2031. Additionally, the report indicates that the market is expected to grow at a compound annual…

Thermal Cameras Market is expected to grow at 7.5% of CAGR through 2024 to 2034, …
The global Thermal Cameras Market (Markt für Wärmebildkameras) has been sailing through robust waters, witnessing a valuation of US$ 3.1 billion in 2023. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2034. By the end of 2034, the industry is expected to anchor at an…

Non-toxic Toys Market Size, Share and Forecast By 2034 | Top Key Players - Panas …
The global Non-toxic Toys Market (無毒おもちゃ市場) has been sailing through robust waters, witnessing a valuation of US$ 23.3 billion in 2023. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 8.5% from 2024 to 2034. By the end of 2034, the industry is expected to anchor at an impressive US$…
More Releases for Autoimmune
Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),…
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru …
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases.
New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companies…
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune …
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616
This latest report researches the industry structure,…
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre …
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attacking…
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market.
Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
To reduce effects of such hindrances, the new entrants are…
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan
Autoimmune disease therapeutics include…